{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:30:19Z","timestamp":1792758619327,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82171947"],"award-info":[{"award-number":["82171947"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005046","name":"Natural Science Foundation of Heilongjiang Province","doi-asserted-by":"publisher","award":["ZD2021H005"],"award-info":[{"award-number":["ZD2021H005"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-024-02995-3","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T17:34:16Z","timestamp":1734543256000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Synergistic SDT\/cuproptosis therapy for liver hepatocellular carcinoma: enhanced antitumor efficacy and specific mechanisms"],"prefix":"10.1186","volume":"22","author":[{"given":"Yucao","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bolin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuikun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"key":"2995_CR1","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.bioactmat.2022.12.010","volume":"24","author":"X Qu","year":"2023","unstructured":"Qu X, Zhou D, Lu J, Qin D, Zhou J, Liu H-J. Cancer nanomedicine in preoperative therapeutics: nanotechnology-enabled neoadjuvant chemotherapy, radiotherapy, immunotherapy, and phototherapy. Bioact Mater. 2023;24:136\u201352. https:\/\/doi.org\/10.1016\/j.bioactmat.2022.12.010.","journal-title":"Bioact Mater"},{"issue":"1","key":"2995_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.trecan.2021.10.003","volume":"8","author":"KB Pointer","year":"2022","unstructured":"Pointer KB, Pitroda SP, Weichselbaum RR. Radiotherapy and immunotherapy: open questions and future strategies. Trends Cancer. 2022;8(1):9\u201320. https:\/\/doi.org\/10.1016\/j.trecan.2021.10.003.","journal-title":"Trends Cancer"},{"issue":"6586","key":"2995_CR3","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, Rossen J, Joesch-Cohen L, Humeidi R, Spangler RD, Eaton JK, Frenkel E, Kocak M, Corsello SM, Lutsenko S, Kanarek N, Santagata S, Golub TR. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375(6586):1254\u201361. https:\/\/doi.org\/10.1126\/science.abf0529.","journal-title":"Science"},{"issue":"37","key":"2995_CR4","doi-asserted-by":"publisher","first-page":"8097","DOI":"10.1002\/adma.201602012","volume":"28","author":"X Qian","year":"2016","unstructured":"Qian X, Zheng Y, Chen Y. Micro\/nanoparticle-augmented sonodynamic therapy (SDT): breaking the depth shallow of photoactivation. Adv Mater. 2016;28(37):8097\u2013129. https:\/\/doi.org\/10.1002\/adma.201602012.","journal-title":"Adv Mater"},{"key":"2995_CR5","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.bioactmat.2022.08.016","volume":"21","author":"N Singh","year":"2023","unstructured":"Singh N, Kim J, Kim J, Lee K, Zunbul Z, Lee I, Kim E, Chi S-G, Kim JS. Covalent organic framework nanomedicines: biocompatibility for advanced nanocarriers and cancer theranostics applications. Bioact Mater. 2023;21:358\u201380. https:\/\/doi.org\/10.1016\/j.bioactmat.2022.08.016.","journal-title":"Bioact Mater"},{"issue":"1","key":"2995_CR6","doi-asserted-by":"publisher","first-page":"2302028","DOI":"10.1002\/adhm.202302028","volume":"13","author":"J Li","year":"2023","unstructured":"Li J, Yue Z, Tang M, Wang W, Sun Y, Sun T, Chen C. Strategies to reverse hypoxic tumor microenvironment for enhanced sonodynamic therapy. Adv Healthc Mater. 2023;13(1):2302028. https:\/\/doi.org\/10.1002\/adhm.202302028.","journal-title":"Adv Healthc Mater"},{"issue":"10","key":"2995_CR7","doi-asserted-by":"publisher","first-page":"6013","DOI":"10.1039\/d0cs00718h","volume":"50","author":"Y Xiong","year":"2021","unstructured":"Xiong Y, Xiao C, Li Z, Yang X. Engineering nanomedicine for glutathione depletion-augmented cancer therapy. Chem Soc Rev. 2021;50(10):6013\u201341. https:\/\/doi.org\/10.1039\/d0cs00718h.","journal-title":"Chem Soc Rev"},{"issue":"5","key":"2995_CR8","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41568-022-00461-6","volume":"22","author":"SK Singh","year":"2022","unstructured":"Singh SK, Singh R. Nanotherapy: targeting the tumour microenvironment. Nat Rev Cancer. 2022;22(5):258\u2013258. https:\/\/doi.org\/10.1038\/s41568-022-00461-6.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2995_CR9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41467-020-20243-8","volume":"12","author":"Z Huang","year":"2021","unstructured":"Huang Z, Wang Y, Yao D, Wu J, Hu Y, Yuan A. Nanoscale coordination polymers induce immunogenic cell death by amplifying radiation therapy mediated oxidative stress. Nat Commun. 2021;12(1):145. https:\/\/doi.org\/10.1038\/s41467-020-20243-8.","journal-title":"Nat Commun"},{"issue":"12","key":"2995_CR10","doi-asserted-by":"publisher","first-page":"3830","DOI":"10.1039\/c6cs00592f","volume":"46","author":"Y Dai","year":"2017","unstructured":"Dai Y, Xu C, Sun X, Chen X. Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment. Chem Soc Rev. 2017;46(12):3830\u201352. https:\/\/doi.org\/10.1039\/c6cs00592f.","journal-title":"Chem Soc Rev"},{"issue":"5","key":"2995_CR11","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41422-022-00653-7","volume":"32","author":"D Tang","year":"2022","unstructured":"Tang D, Chen X, Kroemer G. Cuproptosis: a copper-triggered modality of mitochondrial cell death. Cell Res. 2022;32(5):417\u20138. https:\/\/doi.org\/10.1038\/s41422-022-00653-7.","journal-title":"Cell Res"},{"issue":"22","key":"2995_CR12","doi-asserted-by":"publisher","first-page":"2212267","DOI":"10.1002\/adma.202212267","volume":"35","author":"B Guo","year":"2023","unstructured":"Guo B, Yang F, Zhang L, Zhao Q, Wang W, Yin L, Chen D, Wang M, Han S, Xiao H, Xing N. Cuproptosis induced by ROS responsive nanoparticles with elesclomol and copper combined with \u03b1PD-L1 for enhanced cancer immunotherapy. Adv Mater. 2023;35(22):2212267. https:\/\/doi.org\/10.1002\/adma.202212267.","journal-title":"Adv Mater"},{"issue":"1","key":"2995_CR13","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41392-022-01229-y","volume":"7","author":"L Chen","year":"2022","unstructured":"Chen L, Min J, Wang F. Copper homeostasis and cuproptosis in health and disease. Signal Transduct Target Ther. 2022;7(1):378. https:\/\/doi.org\/10.1038\/s41392-022-01229-y.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2995_CR14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12943-023-01732-y","volume":"22","author":"J Xie","year":"2023","unstructured":"Xie J, Yang Y, Gao Y, He J. Cuproptosis: mechanisms and links with cancers. Mol Cancer. 2023;22(1):46. https:\/\/doi.org\/10.1186\/s12943-023-01732-y.","journal-title":"Mol Cancer"},{"issue":"1","key":"2995_CR15","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41392-022-01014-x","volume":"7","author":"S-R Li","year":"2022","unstructured":"Li S-R, Bu L-L, Cai L. Cuproptosis: lipoylated TCA cycle proteins-mediated novel cell death pathway. Signal Transduct Target Ther. 2022;7(1):158. https:\/\/doi.org\/10.1038\/s41392-022-01014-x.","journal-title":"Signal Transduct Target Ther"},{"key":"2995_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.119761","volume":"234","author":"J An","year":"2020","unstructured":"An J, Hu Y-G, Cheng K, Li C, Hou X-L, Wang G-L, Zhang X-S, Liu B, Zhao Y-D, Zhang M-Z. ROS-augmented and tumor-microenvironment responsive biodegradable nanoplatform for enhancing chemo-sonodynamic therapy. Biomaterials. 2020;234: 119761. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.119761.","journal-title":"Biomaterials"},{"issue":"48","key":"2995_CR17","doi-asserted-by":"publisher","first-page":"2005295","DOI":"10.1002\/adma.202005295","volume":"32","author":"L Sun","year":"2020","unstructured":"Sun L, Xu Y, Zhang X, Gao Y, Chen J, Zhou A, Lu Q, Wang Z, Shao K, Wu H, Ning X. Mesenchymal stem cells functionalized sonodynamic treatment for improving therapeutic efficacy and compliance of orthotopic oral cancer. Adv Mater. 2020;32(48):2005295. https:\/\/doi.org\/10.1002\/adma.202005295.","journal-title":"Adv Mater"},{"issue":"23","key":"2995_CR18","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1039\/d0cc07750j","volume":"57","author":"W Um","year":"2021","unstructured":"Um W, Promod Kumar EK, Lee J, Kim CH, You DG, Park JH. Recent advances in nanomaterial-based augmented sonodynamic therapy of cancer. Chem Commun. 2021;57(23):2854\u201366. https:\/\/doi.org\/10.1039\/d0cc07750j.","journal-title":"Chem Commun"},{"issue":"8","key":"2995_CR19","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/s41423-022-00866-1","volume":"19","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhang L, Zhou F. Cuproptosis: a new form of programmed cell death. Cell Mol Immunol. 2022;19(8):867\u20138. https:\/\/doi.org\/10.1038\/s41423-022-00866-1.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"2995_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nrc3180","volume":"12","author":"A Schroeder","year":"2011","unstructured":"Schroeder A, Heller DA, Winslow MM, Dahlman JE, Pratt GW, Langer R, Jacks T, Anderson DG. Treating metastatic cancer with nanotechnology. Nat Rev Cancer. 2011;12(1):39\u201350. https:\/\/doi.org\/10.1038\/nrc3180.","journal-title":"Nat Rev Cancer"},{"issue":"36","key":"2995_CR21","doi-asserted-by":"publisher","first-page":"H217","DOI":"10.1002\/adma.201102313","volume":"23","author":"FM Kievit","year":"2011","unstructured":"Kievit FM, Zhang M. Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers. Adv Mater. 2011;23(36):H217\u201347. https:\/\/doi.org\/10.1002\/adma.201102313.","journal-title":"Adv Mater"},{"key":"2995_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.119760","volume":"234","author":"S Li","year":"2020","unstructured":"Li S, Saw PE, Lin C, Nie Y, Tao W, Farokhzad OC, Zhang L, Xu X. Redox-responsive polyprodrug nanoparticles for targeted siRNA delivery and synergistic liver cancer therapy. Biomaterials. 2020;234: 119760. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.119760.","journal-title":"Biomaterials"},{"key":"2995_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2147\/ijn.S343361","volume":"17","author":"Y Chen","year":"2022","unstructured":"Chen Y, Shang H, Wang C, Zeng J, Zhang S, Wu B, Cheng W. RNA-Seq explores the mechanism of oxygen-boosted sonodynamic therapy based on all-in-one nanobubbles to enhance ferroptosis for the treatment of HCC. Int J Nanomed. 2022;17:105\u201323. https:\/\/doi.org\/10.2147\/ijn.S343361.","journal-title":"Int J Nanomed"},{"issue":"31","key":"2995_CR24","doi-asserted-by":"publisher","first-page":"2008177","DOI":"10.1002\/smll.202008177","volume":"17","author":"C Zhang","year":"2021","unstructured":"Zhang C, Chen S, Li Q, Wu J, Qiu F, Chen Z, Sun Y, Luo J, Bastarrachea RA, Grayburn PA, DeFronzo RA, Liu Y, Qian K, Huang P. Ultrasound-targeted microbubble destruction mediates gene transfection for beta-cell regeneration and glucose regulation. Small. 2021;17(31):2008177. https:\/\/doi.org\/10.1002\/smll.202008177.","journal-title":"Small"},{"issue":"1","key":"2995_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-021-00835-2","volume":"19","author":"X Xiang","year":"2021","unstructured":"Xiang X, Pang H, Ma T, Du F, Li L, Huang J, Ma L, Qiu L. Ultrasound targeted microbubble destruction combined with Fe-MOF based bio-\/enzyme-mimics nanoparticles for treating of cancer. J Nanobiotechnol. 2021;19(1):1\u201314. https:\/\/doi.org\/10.1186\/s12951-021-00835-2.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"2995_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12951-023-01776-8","volume":"21","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Shi D, Guo L, Shang M, Sun X, Meng D, Xiao S, Wang X, Li J. Ultrasound targeted microbubble destruction-triggered nitric oxide release via nanoscale ultrasound contrast agent for sensitizing chemoimmunotherapy. J Nanobiotechnol. 2023;21(1):35. https:\/\/doi.org\/10.1186\/s12951-023-01776-8.","journal-title":"J Nanobiotechnol"},{"key":"2995_CR27","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.actbio.2021.06.015","volume":"130","author":"J Gao","year":"2021","unstructured":"Gao J, Liu J, Meng Z, Li Y, Hong Y, Wang L, He L, Hu B, Zheng Y, Li T, Cui D, Shen E. Ultrasound-assisted C3F8-filled PLGA nanobubbles for enhanced FGF21 delivery and improved prophylactic treatment of diabetic cardiomyopathy. Acta Biomater. 2021;130:395\u2013408. https:\/\/doi.org\/10.1016\/j.actbio.2021.06.015.","journal-title":"Acta Biomater"},{"issue":"1","key":"2995_CR28","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1038\/s41598-018-21502-x","volume":"8","author":"J Du","year":"2018","unstructured":"Du J, Li X-Y, Hu H, Xu L, Yang S-P, Li F-H. Preparation and imaging investigation of dual-targeted C3F8-filled PLGA nanobubbles as a novel ultrasound contrast agent for breast cancer. Sci Rep. 2018;8(1):3887. https:\/\/doi.org\/10.1038\/s41598-018-21502-x.","journal-title":"Sci Rep"},{"key":"2995_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2019.100800","volume":"29","author":"J Ding","year":"2019","unstructured":"Ding J, Chen J, Gao L, Jiang Z, Zhang Y, Li M, Xiao Q, Lee SS, Chen X. Engineered nanomedicines with enhanced tumor penetration. Nano Today. 2019;29: 100800. https:\/\/doi.org\/10.1016\/j.nantod.2019.100800.","journal-title":"Nano Today"},{"issue":"4","key":"2995_CR30","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.cclet.2020.11.006","volume":"32","author":"J Hu","year":"2021","unstructured":"Hu J, Yuan X, Wang F, Gao H, Liu X, Zhang W. The progress and perspective of strategies to improve tumor penetration of nanomedicines. Chin Chem Lett. 2021;32(4):1341\u20137. https:\/\/doi.org\/10.1016\/j.cclet.2020.11.006.","journal-title":"Chin Chem Lett"},{"issue":"22","key":"2995_CR31","doi-asserted-by":"publisher","first-page":"25825","DOI":"10.1021\/acsami.1c07297","volume":"13","author":"M Liu","year":"2021","unstructured":"Liu M, Ma W, Zhao D, Li J, Li Q, Liu Y, Hao L, Lin Y. Enhanced penetrability of a tetrahedral framework nucleic acid by modification with iRGD for DOX-targeted delivery to triple-negative breast cancer. ACS Appl Mater Interfaces. 2021;13(22):25825\u201335. https:\/\/doi.org\/10.1021\/acsami.1c07297.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"2995_CR32","doi-asserted-by":"publisher","first-page":"2000097","DOI":"10.1002\/adtp.202000097","volume":"4","author":"A Tobi","year":"2020","unstructured":"Tobi A, Willmore AMA, Kilk K, Sidorenko V, Braun GB, Soomets U, Sugahara KN, Ruoslahti E, Teesalu T. Silver nanocarriers targeted with a CendR peptide potentiate the cytotoxic activity of an anticancer drug. Adv Ther. 2020;4(1):2000097. https:\/\/doi.org\/10.1002\/adtp.202000097.","journal-title":"Adv Ther"},{"issue":"1","key":"2995_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-021-00939-9","volume":"19","author":"J Zhang","year":"2021","unstructured":"Zhang J, Zhu J, Zhao L, Mao K, Gu Q, Li D, Zhao J, Wu X. RGD-modified multifunctional nanoparticles encapsulating salvianolic acid A for targeted treatment of choroidal neovascularization. J Nanobiotechnol. 2021;19(1):1\u201316. https:\/\/doi.org\/10.1186\/s12951-021-00939-9.","journal-title":"J Nanobiotechnol"},{"issue":"3","key":"2995_CR34","doi-asserted-by":"publisher","first-page":"708","DOI":"10.7150\/thno.30418","volume":"9","author":"Y Wang","year":"2019","unstructured":"Wang Y, Liu Z, Li T, Chen L, Lyu J, Li C, Lin Y, Hao N, Zhou M, Zhong Z. Enhanced therapeutic effect of RGD-modified polymeric micelles loaded with low-dose methotrexate and nimesulide on rheumatoid arthritis. Theranostics. 2019;9(3):708\u201320. https:\/\/doi.org\/10.7150\/thno.30418.","journal-title":"Theranostics"},{"issue":"1","key":"2995_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-021-00783-x","volume":"19","author":"M Wu","year":"2021","unstructured":"Wu M, Zhong C, Zhang Q, Wang L, Wang L, Liu Y, Zhang X, Zhao X. pH-responsive delivery vehicle based on RGD-modified polydopamine-paclitaxel-loaded poly (3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles for targeted therapy in hepatocellular carcinoma. J Nanobiotechnol. 2021;19(1):1\u201317. https:\/\/doi.org\/10.1186\/s12951-021-00783-x.","journal-title":"J Nanobiotechnol"},{"issue":"7","key":"2995_CR36","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.medj.2022.05.002","volume":"3","author":"I Korsunsky","year":"2022","unstructured":"Korsunsky I, Wei K, Pohin M, Kim EY, Barone F, Major T, Taylor E, Ravindran R, Kemble S, Watts GFM, Jonsson AH, Jeong Y, Athar H, Windell D, Kang JB, Friedrich M, Turner J, Nayar S, Fisher BA, Raza K, Marshall JL, Croft AP, Tamura T, Sholl LM, Vivero M, Rosas IO, Bowman SJ, Coles M, Frei AP, Lassen K, Filer A, Powrie F, Buckley CD, Brenner MB, Raychaudhuri S. Cross-tissue, single-cell stromal atlas identifies shared pathological fibroblast phenotypes in four chronic inflammatory diseases. Med. 2022;3(7):481-518.e14. https:\/\/doi.org\/10.1016\/j.medj.2022.05.002.","journal-title":"Med"},{"issue":"5","key":"2995_CR37","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1038\/s41591-024-02895-x","volume":"30","author":"MF Thomas","year":"2024","unstructured":"Thomas MF, Slowikowski K, Manakongtreecheep K, Sen P, Samanta N, Tantivit J, Nasrallah M, Zubiri L, Smith NP, Tirard A, Ramesh S, Arnold BY, Nieman LT, Chen JH, Eisenhaure T, Pelka K, Song Y, Xu KH, Jorgji V, Pinto CJ, Sharova T, Glasser R, Chan P, Sullivan RJ, Khalili H, Juric D, Boland GM, Dougan M, Hacohen N, Li B, Reynolds KL, Villani A-C. Single-cell transcriptomic analyses reveal distinct immune cell contributions to epithelial barrier dysfunction in checkpoint inhibitor colitis. Nat Med. 2024;30(5):1349\u201362. https:\/\/doi.org\/10.1038\/s41591-024-02895-x.","journal-title":"Nat Med"},{"key":"2995_CR38","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.S28830","author":"R Zheng","year":"2012","unstructured":"Zheng R, Yin T, Wang P, Zheng R, Zheng B, Cheng D, Zhang X, Shuai X-T. Nanobubbles for enhanced ultrasound imaging of tumors. Int J Nanomed. 2012. https:\/\/doi.org\/10.2147\/ijn.S28830.","journal-title":"Int J Nanomed"},{"issue":"9","key":"2995_CR39","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1039\/d1ma00969a","volume":"3","author":"A Tarighatnia","year":"2022","unstructured":"Tarighatnia A, Fouladi MR, Nader ND, Aghanejad A, Ghadiri H. Recent trends of contrast agents in ultrasound imaging: a review of the classifications and applications. Mater Adv. 2022;3(9):3726\u201341. https:\/\/doi.org\/10.1039\/d1ma00969a.","journal-title":"Mater Adv"},{"key":"2995_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104938","author":"A Tarighatnia","year":"2023","unstructured":"Tarighatnia A, Foroughi-Nia B, Nader ND, Aghanejad A. Recent trends and advances in nanosystems with tyrosine kinase inhibitors for image-guided cancer treatments. J Drug Deliv Sci Technol. 2023. https:\/\/doi.org\/10.1016\/j.jddst.2023.104938.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"6","key":"2995_CR41","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s11426-020-9945-4","volume":"64","author":"C Zhang","year":"2021","unstructured":"Zhang C, Li Y, Ma X, He W, Liu C, Liu Z. Functional micro\/nanobubbles for ultrasound medicine and visualizable guidance. Sci China Chem. 2021;64(6):899\u2013914. https:\/\/doi.org\/10.1007\/s11426-020-9945-4.","journal-title":"Sci China Chem"},{"key":"2995_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121975","volume":"293","author":"Y Hao","year":"2023","unstructured":"Hao Y, Chen Y, He X, Han R, Yang C, Liu T, Yang Y, Liu Q, Qian Z. RGD peptide modified platinum nanozyme Co-loaded glutathione-responsive prodrug nanoparticles for enhanced chemo-photodynamic bladder cancer therapy. Biomaterials. 2023;293: 121975. https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121975.","journal-title":"Biomaterials"},{"key":"2995_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultsonch.2021.105629","volume":"76","author":"X Bu","year":"2021","unstructured":"Bu X, Alheshibri M. The effect of ultrasound on bulk and surface nanobubbles: a review of the current status. Ultrason Sonochem. 2021;76: 105629. https:\/\/doi.org\/10.1016\/j.ultsonch.2021.105629.","journal-title":"Ultrason Sonochem"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-024-02995-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-024-02995-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-024-02995-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T18:04:13Z","timestamp":1734545053000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-024-02995-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2995"],"URL":"https:\/\/doi.org\/10.1186\/s12951-024-02995-3","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"assertion":[{"value":"4 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"762"}}